Scalpel Weekly News

Week of: September 18, 2017

IN THE NEWS


EpiPen Failures in Emergencies; Manufacturer Fails to Investigate

On September 5, 2017, the FDA issued a warning letter to Meridian Medical Technologies, Inc., a Pfizer Company, summarizing the significant violations of current good manufacturing practice (CGMP) requirements the agency’s investigators found involving two epinephrine auto-injectors, EpiPen and EpiPen Jr., it manufactures. Click title to continue reading...


 
MEDICAL ALERTS


Intra-Aortic Balloon Pump Recall; False Blood Detection Alarm

On September 6, 2017, Datascope Corp./MAQUET recalled its CS100i, CS100, and CS300 Intra-Aortic Balloon Pumps (IABPs) due to false blood detection alarms and ingress of fluid into the device. If a patient requires circulatory support with an IABP and the device does not work, or if therapy is stopped during use without a replacement IABP available, device failure may result in immediate and serious adverse health consequences, including death. Click title to continue reading...



Potassium-Lowering Drug Decreases Oral Prescription Effectiveness

On September 6, 2017, the FDA recommended that patients avoid taking the potassium-lowering drug sodium polystyrene sulfonate (Kayexalate) at the same time as other medicines taken by mouth. A study found that sodium polystyrene sulfonate binds to many commonly prescribed oral medicines, decreasing the absorption and, therefore, the effectiveness of those oral medicines. Click title to continue reading...



Stroke Death Prevention Rate Stalls; Some Rate Increase

On September 6, 2017, the CDC published a report that found that, after more than four decades of decline, progress has slowed in preventing stroke deaths. Not only has progress slowed among most demographic groups and states, stroke death rates have increased among Hispanics and people living in the South. Click title to continue reading...


  CASE ALERTS


Hospital Notes Written Before Peer Review Process Not Privileged

A 30-weeks-pregnant woman was admitted to the hospital. The woman’s daughter was born that day. The infant suffered from numerous medical issues, including necrotizing enterocolitis. The infant died approximately three weeks later. Click title to continue reading...



Heart Patient Dies after Revascularization; Causation Issue

A man with a history of ischemic heart disease, congestive heart failure, decompensated heart failure, severe vascular disease, diabetes, atrial fibrillation, and stroke underwent a revascularization procedure, a surgical procedure performed to restore an adequate blood supply. Immediately after anesthesia was administered, the man experienced an acute drop in blood pressure. Click title to continue reading...



Pharmacy Insurer’s Indemnity Action Against Pharmacist Barred

A doctor ordered that a man receive the antibiotic tobramycin 5mg/kg intravenously every 24 hours for two weeks. When processing the man’s prescription, the compounding pharmacy discovered that Medicare would not pay for tobramycin. The compounding pharmacy called the doctor and requested permission to substitute gentamicin, a different antibiotic that was covered by Medicare. Click title to continue reading...


FEATURE


Motion to Exclude Expert Liposuction Witness

As a special feature for our Premium subscribers we have included this feature containing an illustrative motion to exclude the plaintiff’s expert witnesses in a liposuction malpractice case. In this illustrative situation, a woman sustained severe injuries as a result of an ultrasonic-assisted liposuction procedure. The woman sued the surgeon and the cosmetic surgery center for negligence. Click title to continue reading...